Protagonist Therapeutics Inc. (PTGX) announced Tuesday morning that it has entered into a worldwide license and collaboration agreement with Janssen Biotech Inc. for the co-development and commercialization of PTG-200.
from RTT - Before the Bell http://ift.tt/2rndStt
via IFTTT
No comments:
Post a Comment